ImmunityBio, Inc. (IBRX)
10.51
+0.60
(+6.05%)
USD |
NASDAQ |
Oct 09, 16:00
10.59
+0.08
(+0.76%)
After-Hours: 20:00
ImmunityBio 30-Day Average Daily Volume : 12.27M for Oct. 9, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 09, 2026 | 12.27M |
| October 08, 2026 | 12.06M |
| October 07, 2026 | 12.02M |
| October 06, 2026 | 12.01M |
| October 05, 2026 | 11.64M |
| October 02, 2026 | 11.33M |
| October 01, 2026 | 10.56M |
| September 30, 2026 | 10.58M |
| September 29, 2026 | 9.855M |
| September 28, 2026 | 9.803M |
| September 25, 2026 | 9.620M |
| September 24, 2026 | 9.626M |
| September 23, 2026 | 9.505M |
| September 22, 2026 | 9.207M |
| September 21, 2026 | 8.703M |
| September 18, 2026 | 8.608M |
| September 17, 2026 | 8.253M |
| September 16, 2026 | 7.998M |
| September 15, 2026 | 8.325M |
| September 14, 2026 | 8.318M |
| September 11, 2026 | 8.325M |
| September 10, 2026 | 8.282M |
| September 09, 2026 | 8.279M |
| September 08, 2026 | 8.359M |
| September 04, 2026 | 8.451M |
| Date | Value |
|---|---|
| September 03, 2026 | 8.591M |
| September 02, 2026 | 8.620M |
| September 01, 2026 | 8.675M |
| August 31, 2026 | 8.747M |
| August 28, 2026 | 8.759M |
| August 27, 2026 | 8.794M |
| August 26, 2026 | 8.640M |
| August 25, 2026 | 8.549M |
| August 24, 2026 | 8.413M |
| August 21, 2026 | 8.553M |
| August 20, 2026 | 8.728M |
| August 19, 2026 | 8.837M |
| August 18, 2026 | 8.726M |
| August 17, 2026 | 8.920M |
| August 14, 2026 | 9.142M |
| August 13, 2026 | 9.468M |
| August 12, 2026 | 9.816M |
| August 11, 2026 | 9.948M |
| August 10, 2026 | 10.31M |
| August 07, 2026 | 11.48M |
| August 06, 2026 | 11.48M |
| August 05, 2026 | 11.77M |
| August 04, 2026 | 11.77M |
| August 03, 2026 | 11.46M |
| July 31, 2026 | 11.65M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Moderna, Inc. | 17.01M |
| Sarepta Therapeutics, Inc. | 2.927M |
| Arrowhead Pharmaceuticals, Inc. | 2.142M |
| Oncolytics Biotech, Inc. | 1.076M |
| Sangamo Therapeutics, Inc. | 1.824M |